Develops medicines for various diseases and health conditions.
Jun 2026Revenue $14.7B/yrExpenses $14.8B/yr
No trend
Figures by year
When will Viatris be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $14.7B and expenses $14.8B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $14.3B | $17.0B | −$2.66B |
| Dec 2024 | $14.7B | $14.7B | $10.1M |
| Dec 2023 | $15.4B | $14.7B | $766M |
| Dec 2022 | $16.3B | $14.6B | $1.61B |
| Dec 2021 | $17.9B | $17.9B | −$34.0M |
| Dec 2020 | $11.9B | $12.2B | −$211M |
| Dec 2019 | $11.5B | $10.8B | $716M |
| Dec 2018 | $11.4B | $10.5B | $906M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.